Industry Strength Score
21/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
IQVIA HOLDINGS INC (IQV) Stock Price & Overview
NYSE:IQV • US46266C1053
Current stock price
158.37 USD
+1.71 (+1.09%)
At close:
158.373 USD
0 (0%)
After Hours:
The current stock price of IQV is 158.37 USD. Today IQV is up by 1.09%. In the past month the price decreased by -8.14%. In the past year, price increased by 3.19%.
IQV Key Statistics
52-Week Range134.645 - 247.045
Current IQV stock price positioned within its 52-week range.
1-Month Range154.5 - 180.98
Current IQV stock price positioned within its 1-month range.
- Market Cap
- 26.586B
- P/E
- 13.27
- Fwd P/E
- 12.35
- EPS (TTM)
- 11.93
- Dividend Yield
- N/A
IQV Stock Performance
Today
+1.09%
1 Week
-1.44%
1 Month
-8.14%
3 Months
-31.19%
Longer-term
6 Months -26.84%
1 Year +3.19%
2 Years -31.67%
3 Years -15.86%
5 Years -32.52%
10 Years N/A
IQV Stock Chart
IQV Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to IQV. When comparing the yearly performance of all stocks, IQV is a bad performer in the overall market: 82.62% of all stocks are doing better.
Chartmill TA Rating
Chartmill Setup Rating
IQV Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to IQV. While IQV has a great profitability rating, there are quite some concerns on its financial health.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IQV Earnings
On February 5, 2026 IQV reported an EPS of 3.42 and a revenue of 4.36B. The company missed EPS expectations (-0.33% surprise) and beat revenue expectations (1.91% surprise).
Next Earnings DateMay 5, 2026
Last Earnings DateFeb 5, 2026
PeriodQ4 / 2025
EPS Reported$3.42
Revenue Reported4.364B
EPS Surprise -0.33%
Revenue Surprise 1.91%
IQV Forecast & Estimates
31 analysts have analysed IQV and the average price target is 238.98 USD. This implies a price increase of 50.9% is expected in the next year compared to the current price of 158.37.
For the next year, analysts expect an EPS growth of 7.52% and a revenue growth 6.51% for IQV
Analysts
Analysts83.87
Price Target238.98 (50.9%)
EPS Next Y7.52%
Revenue Next Year6.51%
IQV Index Membership
IQV is currently included in the following stock indexes tracked on ChartMill.
IQV Financial Highlights
Over the last trailing twelve months IQV reported a non-GAAP Earnings per Share(EPS) of 11.93. The EPS increased by 7.09% compared to the year before.
Income Statements
Revenue(TTM)16.31B
Net Income(TTM)1.36B
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.34% | ||
| ROA | 4.54% | ||
| ROE | 20.91% | ||
| Debt/Equity | 2.14 |
Chartmill High Growth Momentum
EPS Q2Q%9.62%
Sales Q2Q%10.26%
EPS 1Y (TTM)7.09%
Revenue 1Y (TTM)5.87%
IQV Ownership
Ownership
Inst Owners103.46%
Shares167.87M
Float166.02M
Ins Owners0.95%
Short Float %2.89%
Short Ratio2.58
IQV Industry Overview
IQV operates in the Life Sciences Tools & Services sub-industry within the Health Care sector. This group contains 51 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
54/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
40%
Outperformed 40% of sub-industries
3 Month Rank
8%
Outperformed 8% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 51
- New Highs
- 0%
- New Lows
- 5.9%
- Average ROE
- 14.9%
- Average Profit Margin
- 15.8%
- Average Operating Margin
- 18.7%
- Average P/E
- 33.4
- Average Fwd P/E
- 28.9
- Average Debt/Equity
- 0.8
IQV Competitors/Peers
The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 17.68 | 173.272B | ||
| DHR | DANAHER CORP | 19.44 | 126.537B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 135.66 | 41.885B | ||
| A | AGILENT TECHNOLOGIES INC | 17.2 | 31.453B | ||
| WAT | WATERS CORP | 21.27 | 28.678B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 27.18 | 25.113B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 33.11 | 21.29B | ||
| ILMN | ILLUMINA INC | 24.22 | 18.285B | ||
| MEDP | MEDPACE HOLDINGS INC | 21.63 | 11.812B | ||
| RVTY | REVVITY INC | 15.74 | 9.197B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 8.974B | ||
| TECH | BIO-TECHNE CORP | 24.9 | 8.128B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About IQV
Company Profile
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Company Info
IPO: 2013-05-09
IQVIA HOLDINGS INC
2400 Ellis Road
Durham NORTH CAROLINA 27703 US
CEO: Ari Bousbib
Employees: 93000
Phone: 19199982000
IQVIA HOLDINGS INC / IQV FAQ
Can you describe the business of IQVIA HOLDINGS INC?
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Can you provide the latest stock price for IQVIA HOLDINGS INC?
The current stock price of IQV is 158.37 USD. The price increased by 1.09% in the last trading session.
Does IQV stock pay dividends?
IQV does not pay a dividend.
How is the ChartMill rating for IQVIA HOLDINGS INC?
IQV has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
On which exchange is IQV stock listed?
IQV stock is listed on the New York Stock Exchange exchange.
What is the next earnings date for IQV stock?
IQVIA HOLDINGS INC (IQV) will report earnings on 2026-05-05, before the market open.
Who owns IQVIA HOLDINGS INC?
You can find the ownership structure of IQVIA HOLDINGS INC (IQV) on the Ownership tab.